✦ LIBER ✦
A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial
✍ Scribed by Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem; W. Ross Stevens; David Bluemke; Rendon Nelson; Patrick Fultz; Peter Reimer; Vincent Ho; Rita M. Kristy; Joseph A. Pierro
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 286 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.